Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Barlocco

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Current Medicinal Chemistry|February 7, 2006
Privileged structures as leads in medicinal chemistryLuca Costantino, Daniela Barlocco
Current Medicinal Chemistry|February 5, 2020
Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer ChemotherapyEftiola Pojani, Daniela Barlocco
Current Medicinal Chemistry|September 1, 2021
Selective Inhibitors of Histone Deacetylase 10 (HDAC-10)Eftiola Pojani, Daniela Barlocco
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Novel Antibacterial Agents 2022Fiorella Meneghetti, Daniela Barlocco
Expert Opinion on Therapeutic Patents|July 23, 2014
Ghrelin receptor modulators: a patent review (2011 - 2014)Luca Costantino, Daniela Barlocco
Current Medicinal Chemistry|May 14, 2008
STAT 3 as a target for cancer drug discoveryLuca Costantino, Daniela Barlocco
Future Medicinal Chemistry|April 30, 2011
Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapyDaniela Masciocchi, Arianna Gelain, Stefania Villa, et al.
Journal of Combinatorial Chemistry|September 14, 2004
Solid-phase convergent synthesis of a benzimidazolone library via the combination of two smaller arrays of carboxylic acids and secondary aminesIvana Bianchi, Elena La Porta, Daniela Barlocco, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Congo red analogues as potential anti-prion agentsStefania Villa, Giorgio Cignarella, Daniela Barlocco, et al.
Current Medicinal Chemistry|June 10, 2016
Iron Acquisition Pathways as Targets for Antitubercular DrugsFiorella Meneghetti, Stefania Villa, Arianna Gelain, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Current Medicinal Chemistry|February 7, 2006
Privileged structures as leads in medicinal chemistryLuca Costantino, Daniela Barlocco
Current Medicinal Chemistry|February 5, 2020
Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer ChemotherapyEftiola Pojani, Daniela Barlocco
Current Medicinal Chemistry|September 1, 2021
Selective Inhibitors of Histone Deacetylase 10 (HDAC-10)Eftiola Pojani, Daniela Barlocco
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Novel Antibacterial Agents 2022Fiorella Meneghetti, Daniela Barlocco
Expert Opinion on Therapeutic Patents|July 23, 2014
Ghrelin receptor modulators: a patent review (2011 - 2014)Luca Costantino, Daniela Barlocco
Current Medicinal Chemistry|May 14, 2008
STAT 3 as a target for cancer drug discoveryLuca Costantino, Daniela Barlocco
Future Medicinal Chemistry|April 30, 2011
Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapyDaniela Masciocchi, Arianna Gelain, Stefania Villa, et al.
Journal of Combinatorial Chemistry|September 14, 2004
Solid-phase convergent synthesis of a benzimidazolone library via the combination of two smaller arrays of carboxylic acids and secondary aminesIvana Bianchi, Elena La Porta, Daniela Barlocco, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Congo red analogues as potential anti-prion agentsStefania Villa, Giorgio Cignarella, Daniela Barlocco, et al.
Current Medicinal Chemistry|June 10, 2016
Iron Acquisition Pathways as Targets for Antitubercular DrugsFiorella Meneghetti, Stefania Villa, Arianna Gelain, et al.
Pageof 4